Location: Israel
Sight developed the OLO device to provide a point-of-care option for doctors clinics.
90% of the healthcare facilities in the US are not able to perform a full blood count (FBC) on site. That means of the 185 million FBCs ordered each year; the vast majority are sent to an outside laboratory for testing. Results can take days and may require second appointments to get the results. The full blood count is a general test; looking at the type and number of cells in your blood. It’s a basic test used to help detect things like anaemia, infection and general health.
Sight Diagnostics has developed OLO, an easy-to-use device that provides results almost instantly. It only takes two drops of blood onto a disposable cartridge which is placed in the instrument – The preparation typically takes 15 seconds. The device’s AI algorithm analyses the sample and provides 19 full blood count parameters on the built-in screen. Results can be printed out and e-mailed.
Having a point-of-care option for such a commonly used test can save both patients and healthcare systems time and money. It will allow doctors to make more informed decisions about treatment plans during a single visit. The company was initially using this type of technology to help with malaria detection. Point-of-care diagnostics are valuable and increasingly possible because of technological advances. 1drop diagnostics is another company testing drops of blood, but those that are related to heart health.
Website: https://www.sightdx.com/international
Email: info@sightdx.com
Image: Sight Diagnostics
